about
Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and ObesityDiabetes and cancer: two diseases with obesity as a common risk factorEmerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerPPARγ as a Novel Therapeutic Target in Lung CancerComparative mitochondrial proteomic analysis of hepatocellular carcinoma from patientsAnticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγTopic model-based mass spectrometric data analysis in cancer biomarker discovery studiesA putative role for platelet-derived PPARγ in vascular homeostasis demonstrated by anti-PPARγ induction of bleeding, thrombocytopenia and compensatory megakaryocytopoiesisLigand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.T0070907, a PPAR γ inhibitor, induced G2/M arrest enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe.Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancerMetabolic syndrome and cancerActivation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone.Exploring the Functional Disorder and Corresponding Key Transcription Factors in Intraductal Papillary Mucinous Neoplasms Progression.Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cellsPeroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model.Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress.DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer CellsInhibition of Myc family proteins eradicates KRas-driven lung cancer in micePPARs Mediate Lipid Signaling in Inflammation and Cancer.Identification of an inter-transcription factor regulatory network in human hepatoma cells by Matrix RNAi.Relationships between pulmonary micro-RNA and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents.Asiatic acid isolated from Centella asiatica inhibits TGF-β1-induced collagen expression in human keloid fibroblasts via PPAR-γ activation.The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney diseaseA human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humansPPAR Agonists for the Prevention and Treatment of Lung Cancer.HCV and oxidative stress in the liver.Potential role of tocotrienols in the treatment and prevention of breast cancer.Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.Altered Pathway Analyzer: A gene expression dataset analysis tool for identification and prioritization of differentially regulated and network rewired pathways.Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies.Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis.Assessment of histone tail modifications and transcriptional profiling during colon cancer progression reveals a global decrease in H3K4me3 activity.
P2860
Q26772316-D5F7C347-CDA5-4B5A-BDB7-78516E23C07AQ26822753-FDF2FDE7-D8EC-40B2-9459-8B22ED055972Q26829126-9910A83D-18A8-409D-8495-AAD686FE3072Q28068114-EADD57D5-1041-49CA-9E96-E62AA82D5019Q28289016-32C32B33-77A8-4BEF-8AA5-E7AA6CBED7AFQ28541836-0119F378-6F3F-4342-B67C-0018F34D6AE8Q31122171-BB85EB39-8762-4509-A4D5-491CED0E8D88Q33392128-AFB8332B-2421-4224-8897-FB829D0A1458Q33503634-F6F12848-BD9C-4F5F-87DC-78B93A2DBFF1Q33688755-539B48C2-1B60-400A-B205-597519094993Q33692555-48B50DED-BF24-4A4C-9153-514C5AA2CCB2Q34084838-8DBD7613-AA88-4DE3-87F3-F411EF062503Q34417994-C0FA2156-798C-4C4A-9AA0-7FDFC37A031DQ34646513-6246CF2F-6035-4B40-A80E-8AAB77CF64F6Q35034870-61D0DCB0-0BDF-4717-89D7-A4501EF04863Q35319301-468804F9-6284-4C54-BE96-D767A35CDD26Q36068879-F923204C-E4D4-47D0-9D28-C33B0CF90BD1Q36069761-89275CFD-AB31-4E6E-907C-CA1716370D12Q36158956-3BDD09B7-292C-4B13-ACC9-40032620F71DQ36261125-2DC080E0-30EE-4538-B6A3-2A842AC192F5Q36284318-FE9A52ED-0CD9-4DD6-9D4D-7B4055C0E1F9Q36429362-8CD430F5-E0D1-478E-A823-CCC9EE96BB7FQ36499766-10D9DB2D-58CE-416B-8B8B-13B0671A937AQ36505700-B11B50B0-7EA9-4A40-BF69-AE2E82486243Q36602967-DFBA637A-50ED-4803-B4EB-AD35762E1952Q36708046-E1135926-897A-417E-9747-8173281EB166Q37021709-D0930F76-F708-48C2-9BB1-445C378B10A1Q37118767-B675F4B9-DB90-4CCC-A9EE-A63F33427997Q37205860-9253622B-6301-4CDD-BC25-381651DD76E0Q37317161-AF02BFAE-E746-41C5-9D8E-A8DE9E69C345Q37464712-0EBB2679-8F99-4F42-9281-5D36B6ACCE9EQ37626434-D949369B-C737-4BAA-8395-91C13E319956Q37681630-08457C47-96F4-46A0-8801-3C9FB49E1E13Q38077447-2146A333-692A-41AC-A922-9A7FDA5D2C0DQ38117310-77EB4640-8C57-4AE0-89F5-FB8ECFC7978DQ38694206-545DA052-B0D9-4B48-830A-79FB51670D74Q38721502-5FF08751-0B7E-4AE3-8CD9-2FBDCB4EFBA6Q38721726-B79CCA97-E2D1-47A0-97E9-DB360A372AECQ38726257-3AEC6D82-97BB-4A36-A0AA-D8AEC5610419Q38743268-86E4E56E-0A84-489D-95E1-73E98C42661A
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The Role of PPARs in Cancer
@ast
The Role of PPARs in Cancer
@en
The Role of PPARs in Cancer
@en-gb
The Role of PPARs in Cancer
@nl
type
label
The Role of PPARs in Cancer
@ast
The Role of PPARs in Cancer
@en
The Role of PPARs in Cancer
@en-gb
The Role of PPARs in Cancer
@nl
prefLabel
The Role of PPARs in Cancer
@ast
The Role of PPARs in Cancer
@en
The Role of PPARs in Cancer
@en-gb
The Role of PPARs in Cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
The Role of PPARs in Cancer
@en
P2093
Daisuke Yamasaki
Keisuke Tachibana
Kenji Ishimoto
Takefumi Doi
P2860
P304
P3181
P356
10.1155/2008/102737
P407
P577
2008-01-01T00:00:00Z